- Home
- BHC
as 06-20-2025 4:00pm EST
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
| Founded: | N/A | Country: | Canada |
| Employees: | N/A | City: | QUEBEC |
| Market Cap: | 1.7B | IPO Year: | N/A |
| Target Price: | $7.20 | AVG Volume (30 days): | 2.5M |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.96 - $9.85 | Next Earning Date: | 07-31-2025 |
| Revenue: | $9,731,000,000 | Revenue Growth: | 8.53% |
| Revenue Growth (this year): | 3.71% | Revenue Growth (next year): | 5.03% |
Stock Insider Trading Activity of Bausch Health Companies Inc. (BHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Paulson John | BHC | Director | Jun 13 '25 | Buy | $5.94 | 3,564,059 | $21,170,510.46 | 32,791,702 | |
| Paulson John | BHC | Director | Jun 10 '25 | Buy | $5.25 | 2,788,608 | $14,700,256.94 | 32,791,702 |
Latest Bausch Health Companies Inc. News
BHC Breaking Stock News: Dive into BHC Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Bausch Health Companies Insider Bought Shares Worth $21,170,510, According to a Recent SEC Filing
Insider Monkey
7 days ago
Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds
MT Newswires
8 days ago
Bausch Health Companies Insider Bought Shares Worth $14,700,257, According to a Recent SEC Filing
MT Newswires
11 days ago
Bausch + Lomb Launches $685 Million Notes Offering, Refinances Credit Facilities
MT Newswires
11 days ago
Bausch + Lomb Launching Senior Secured Notes Offering and Refinancing Credit Agreement
MT Newswires
17 days ago
Bausch + Lomb Launches New Lubricating Eye Drops in the U.S.
Zacks
22 days ago
Why Is Bausch (BHC) Down 13% Since Last Earnings Report?
Simply Wall St.
23 days ago
With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns
Compare BHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BHC Bausch Health Companies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.